12.88

1.45% -0.23

Edgewise Therapeutics Inc (EWTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$13.11

Offen:

$13.065

24-Stunden-Volumen:

63,555

Relative Volume:

0.04

Marktkapitalisierung:

$1.63B

Einnahmen:

Nettoeinkommen (Verlust:

$-115.88M

KGV:

-8.3269

EPS:

-1.5468

Netto-Cashflow:

$-104.72M

1W Leistung:

-12.41%

1M Leistung:

-9.52%

6M Leistung:

-51.61%

1J Leistung:

-33.33%

1-Tages-Spanne:

$12.84

$13.16

1-Wochen-Bereich:

$12.15

$14.78

52-Wochen-Spanne:

$10.60

$38.12

Edgewise Therapeutics Inc Stock (EWTX) Company Profile

Firmenname

Edgewise Therapeutics Inc

Sektor

Healthcare (1174)

Branche

Biotechnology (661)

Telefon

720-262-7002

Adresse

1715 38TH ST, BOULDER

Mitarbeiter

117

Twitter

Nächster Verdiensttermin

2025-03-03

Neueste SEC-Einreichungen

EWTX's Discussions on Twitter

Vergleichen Sie EWTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EWTX Edgewise Therapeutics Inc	12.90	1.63B	0	-115.88M	-104.72M	-1.5468
VRTX Vertex Pharmaceuticals Inc	447.19	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	526.49	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	322.93	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	562.46	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	240.60	28.51B	3.81B	-644.79M	-669.77M	-6.24

Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-30	Eingeleitet	Guggenheim	Buy
2025-04-02	Herabstufung	Scotiabank	Sector Outperform → Sector Perform
2025-03-07	Eingeleitet	Scotiabank	Sector Outperform
2025-01-22	Eingeleitet	Stifel	Hold
2024-11-22	Eingeleitet	Evercore ISI	Outperform
2024-03-07	Eingeleitet	Piper Sandler	Overweight
2023-05-01	Eingeleitet	Truist	Buy
2022-08-25	Herabstufung	Goldman	Neutral → Sell
2022-04-13	Eingeleitet	RBC Capital Mkts	Outperform
2022-01-28	Eingeleitet	Goldman	Neutral

Alle ansehen

Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten

Jun 18, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.8%Here's What Happened - MarketBeat

Jun 18, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stake Boosted by GAMMA Investing LLC - MarketBeat

Jun 18, 2025

Jun 17, 2025

Rhumbline Advisers Purchases 6,440 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Jun 17, 2025

Jun 14, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Average PT from Analysts - MarketBeat

Jun 14, 2025

Jun 13, 2025

Enliven to sell $200M in stock after positive drug trial - BizWest

Jun 13, 2025

Jun 10, 2025

Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - MSN

Jun 10, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jun 10, 2025

Jun 09, 2025

Transcript : Edgewise Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener

Jun 09, 2025

Bank of America Corp DE Has $1.31 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 09, 2025

Jun 08, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Receives "Outperform" Rating from Royal Bank of Canada - MarketBeat

Jun 08, 2025

Jun 07, 2025

Ameriprise Financial Inc. Purchases Shares of 22,584 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 07, 2025

Royal Bank of Canada Reaffirms Outperform Rating for Edgewise Therapeutics (NASDAQ:EWTX) - Defense World

Jun 07, 2025

Jun 06, 2025

Bank of America Corp DE Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Jun 06, 2025

Jun 05, 2025

Edgewise Therapeutics (EWTX) Receives Reaffirmed 'Outperform' Ra - GuruFocus

Jun 05, 2025

RBC Capital maintains outperform rating on Edgewise Therapeutics stock By Investing.com - Investing.com India

Jun 05, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 05, 2025

Jun 04, 2025

Universal Beteiligungs und Servicegesellschaft mbH Invests $2.40 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 04, 2025

Edgewise Therapeutics to Present at the Annual Goldman Sachs Global Healthcare Conference - Eastern Progress

Jun 04, 2025

Jun 03, 2025

Muscle Disease Leader Edgewise Therapeutics Set for Key Goldman Sachs Healthcare Conference Presentation - Stock Titan

Jun 03, 2025

Jun 02, 2025

Two Sigma Investments LP Has $3.52 Million Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 02, 2025

Jun 01, 2025

Certain Stock Options of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JUN-2025. - marketscreener.com

Jun 01, 2025

Certain Common Stock of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JUN-2025. - marketscreener.com

Jun 01, 2025

(EWTX) Technical Data - news.stocktradersdaily.com

Jun 01, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Nuveen Asset Management LLC - MarketBeat

Jun 01, 2025

May 31, 2025

Polar Asset Management Partners Inc. Has $1.72 Million Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 31, 2025

May 29, 2025

Edgewise Therapeutics: Upcoming DMD Trial Data May Disappoint (NASDAQ:EWTX) - Seeking Alpha

May 29, 2025

May 28, 2025

Nuveen Asset Management LLC Acquires 158,452 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

May 28, 2025

May 27, 2025

Woodline Partners LP Has $15.15 Million Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 27, 2025